Hosted on MSN9mon
Eli Lilly says weight-loss drug Zepbound proved effective as a treatment for sleep apnea
The Phase 3 trials dubbed Surmount-OSA evaluated Zepbound in adults with moderate-to-severe OSA with the first trial involving patients who were not on positive airway pressure, or PAP ...
Hosted on MSN9mon
Eli Lilly obesity therapy succeeds in late-stage trials for sleep disorder
Lilly's (LLY) SURMOUNT-OSA program, which involved 469 adults with moderate-to-severe OSA and obesity across multiple countries, also reached a key secondary endpoint based on the percentage ...
pharmaphorum6d
Trials set up filing for Lilly’s tirzepatide in sleep apnoea
SURMOUNT-OSA Study 1 recruited patients with OSA who were not on positive airway pressure (PAP) therapy, in which a mask is worn during sleep that blows air into the lungs and keeps the airway open.
Zawya29d
FDA approves Tirzepatideas: The first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
This approval was based on results from the SURMOUNT-OSA phase 3 clinical trials, which evaluated Tirzepatide (10 mg or 15 mg) for the treatment of moderate-to-severe OSA in adults with obesity, with ...
pharmaphorum3d
Lilly grabs first-ever FDA nod for a sleep apnoea drug
FDA said the benefit of Zepbound "is likely related to body weight reduction." Patients in the SURMOUNT-OSA studies had an average weight loss of around 20% with Zepbound and PAP treatment and ...
Medscape5mon
Brief Reports
Commentary, September 09, 2024 ADA 2024 SURMOUNT-OSA Results: 'Impressive' in Improving Sleep Apnea Drs Akshay Jain and James Kim discuss the benefits of GLP-1 therapy for sleep apnea, as reported ...
Intelligent Investor7mon
The doom study and what it means for ResMed
This can lead to some large bumps in the road, as ResMed just discovered. On Saturday, Eli Lilly released the results of a highly anticipated clinical trial called SURMOUNT-OSA. The Phase III study ...